MicroRNA-21 aggravates chronic obstructive pulmonary disease by promoting autophagy

Zhengpeng Zeng1, ShengYang He1, JunJuan Lu1

  • 1a Center for Experimental Medical Research , the Third Xiangya Hospital of Central South University , Changsha , Hunan , P.R. China.

Insights

MicroRNA-21 (miR-21) promotes autophagy and apoptosis in chronic obstructive pulmonary disease (COPD). Inhibiting miR-21 reduces these effects, offering potential therapeutic targets for COPD.

Area of Science:

  • Pulmonary Medicine
  • Molecular Biology
  • Cellular Biology

Background:

  • MicroRNAs and autophagy are implicated in chronic obstructive pulmonary disease (COPD) pathogenesis.
  • Understanding the specific roles of microRNAs, like miR-21, in COPD is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the role of microRNA-21 (miR-21) in mediating autophagy in the context of COPD.
  • To determine the impact of miR-21 on apoptosis in human bronchial epithelial cells exposed to cigarette smoke.

Main Methods:

  • Utilized C57BL/6 mice and miR-21 knockout (miR-21-/-) mice models.
  • Employed human bronchial epithelial (16HBE) cells exposed to cigarette smoke extract (CSE).
  • Assessed autophagy levels and miR-21 expression in lung tissues and cell cultures; employed miR-21 inhibitors.

Main Results:

  • COPD model mice exhibited significantly higher autophagy levels compared to controls.
  • miR-21 knockout mice showed reduced autophagy compared to the COPD model.
  • CSE exposure upregulated miR-21 expression and increased autophagy in 16HBE cells.
  • miR-21 inhibition decreased CSE-induced autophagy and apoptosis in 16HBE cells.

Conclusions:

  • MicroRNA-21 plays a significant role in inducing autophagy in COPD.
  • miR-21 promotes apoptosis in human bronchial epithelial cells relevant to COPD.
  • These findings highlight miR-21 as a potential therapeutic target for managing COPD progression.

Related Concept Videos

Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.6K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.7K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.9K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.2K
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
5.3K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.9K